Lehrnbecher, T;
Phillips, R;
Alexander, S;
Alvaro, F;
Carlesse, F;
Fisher, B;
Hakim, H;
Santolaya, M;
Castagnola, E;
Davis, B. L;
Dupuis, L. L;
Gibson, F;
Groll, A. H;
Gaur, A;
Gupta, A;
Kebudi, R;
Petrilli, S. L;
Steinbach, W. J;
Villarroel, M;
Zaoutis, T Sung.
To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient...
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Multiple Sclerosis/therapy,
Multiple Sclerosis/diagnostic imaging,
Multiple Sclerosis/drug therapy,
Magnetic Resonance Spectroscopy/methods,
Interferon-beta/therapeutic use,
Glatiramer Acetate/therapeutic use,
Azathioprine/therapeutic use,
Natalizumab/therapeutic use,
Fingolimod Hydrochloride/therapeutic use,
Mitoxantrone/therapeutic use,
Methotrexate/therapeutic use,
Cyclophosphamide/therapeutic use,
Hematopoietic Stem Cell Transplantation,
Adrenal Cortex Hormones/therapeutic use
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Antibodies, Monoclonal,
Antibodies,
Antibodies, Monoclonal, Murine-Derived/therapeutic use,
Antineoplastic Agents,
Drug Administration Schedule,
Hematopoietic Stem Cell Transplantation,
Lymphoma, Follicular/pathology,
Lymphoma/therapy,
Neoplasm Staging,
Rituximab,
Time Factors
